Is a complete SHE/300519 research report available?

No complete published report is available for she/300519 (SHE/300519) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/300519 stock profile: metrics, valuation and analysis

Market cap	2.3B
Revenue (ttm)	267M
Net income (ttm)	62M
EPS (ttm)	CN¥0.39
Shares out	160M
P/E (trailing)	36.8x
Dividend	CN¥0.30 (2.09%)
Volume	349,131
Beta	0.31

All SHE/300519 indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	309
Employees Change	-7%
Employees Change Percent	-2.22
Enterprise value	CNY 1.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	35.4
Industry PE Fwd	17.7
Isin	CNE1000027T3
Last refreshed	2026-09-08
Market cap	CNY 2.3B
Price	CNY 14.33
Price currency	CNY
Rev Per Employee	864,109.98x
Sector	Healthcare
Sector PE	40.46
Sector PE Fwd	21.02
Sic	2834
Symbol	she/300519
Website	https://www.xgpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.7%
EV Earnings	25.19x
EV/EBIT	24.6x
EV/EBITDA	20.15x
EV/FCF	17.47x
EV/Sales	5.85x
FCF yield	3.9%
P/B ratio	2.77x
P/E ratio	36.79x
P/S ratio	8.59x
PE Ratio10 Y	34.03x
PE Ratio3 Y	40.27x
PE Ratio5 Y	34.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.78%
EBITDA Margin	29.03%
FCF margin	33.49%
Gross margin	43.56%
Gross Profit	CNY 116.3M
Gross Profit Growth	26.32%
Gross Profit Growth Q	47.94%
Gross Profit Growth3 Y	-9.73%
Gross Profit Growth5 Y	-8%
Net Income	CNY 62M
Net Income Growth	9.2%
Net Income Growth Q	81.16%
Net Income Growth Qo Q	-49.39%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-10.82%
Pretax Margin	27.19%
Profit Margin	23.23%
Profit Per Employee	CNY 200,698
Profitable Quarters	CNY 46
Profitable Years	15
ROA	4.5
Roa5y	4.68
ROCE	7.59
ROE	7.55
Roe5y	9.3
ROIC	57.13
Roic5y	45.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-11%
Cagr1y	-10.14%
Cagr3y	0.89%
Cagr5y	-0.67%
Div CAGR3	-15.66%
Div CAGR5	-12.94%
EPS Growth	11.61
EPS Growth Q	84.21
EPS Growth Qo Q	-45.45
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	-10.29
EPS Growth5 Y	-10.78
FCF Growth	51.75%
FCF Growth Qo Q	-88.76%
FCF Growth3 Y	3.56%
FCF Growth5 Y	-3.84%
OCF Growth	42.36%
OCF Growth Qo Q	-88.47%
OCF Growth10 Y	-2.4%
OCF Growth3 Y	1.62%
OCF Growth5 Y	-7.08%
Revenue Growth	1.76x
Revenue Growth Q	13.48x
Revenue Growth Qo Q	-38.82x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.82x
Revenue Growth5 Y	-3.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.3
Assets	CNY 882.4M
Cash	CNY 732M
Current Assets	CNY 773.6M
Current Liabilities	CNY 46.2M
Debt	CNY 0
Equity	CNY 829M
Liabilities	CNY 53.4M
Long Term Assets	CNY 108.9M
Long Term Liabilities	CNY 7.3M
Net Cash	CNY 732M
Net Cash By Market Cap	CNY 31.9
Net Cash Growth	8.24%
Net Debt EBITDA	CNY -9.44
Net Debt Equity	CNY -0.88
Net Debt FCF	CNY -8.19
Tangible Book Value	CNY 821.6M
Tangible Book Value Per Share	CNY 5.37
WACC	5.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.76
Inventory Turnover	3.33
Net Working Capital	CNY -4.6M
Quick ratio	16.11
Working Capital	CNY 727.4M
Working Capital Turnover	CNY 0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.16%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.3
Dividend Years	10
Dividend Yield	2.09%
Ex Div Date	2026-05-29
Last Dividend	CNY 0.3
Payout Frequency	Annual
Payout Ratio	77.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-68.8%
1Y total return	-10.13%
200-day SMA	15.02
3Y total return	2.69%
50-day SMA	13.76
50-day SMA vs 200-day SMA	50under200
5Y total return	-3.32%
All Time High	66.5
All Time High Change	-78.44%
All Time High Date	2016-08-18
All Time Low	7.67
All Time Low Change	86.96%
All Time Low Date	2016-06-24
ATR	0.64
Beta	0.31
Beta1y	0.28
Beta2y	0.48
Ch YTD	-3.76
High	14.35
High52	18.25
High52 Date	2025-12-08
High52ch	-21.48%
Low	14.22
Low52	11.53
Low52 Date	2026-06-29
Low52ch	24.28%
Ma50ch	4.21%
Price vs 200-day SMA	-4.51%
RSI	50.05
RSI Monthly	48.68
RSI Weekly	49.46
Sharpe ratio	-0.32x
Sharpe Ratio3y	0.11x
Sharpe Ratio5y	0.13x
Sortino ratio	-0.3
Sortino Ratio3y	0.28
Sortino Ratio5y	0.31
Total Return	4.25%
Tr YTD	-1.69
Tr1m	1.92%
Tr1w	-0.97%
Tr3m	6.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,000,100%
Shares Insiders	38.25%
Shares Institutions	1.45%
Shares Out	160,000,000
Shares Qo Q	-7.22%
Shares Yo Y	-2.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,887,980.45x
Bv Per Share	5.42
CAPEX	CNY -445,169
Ch10y	-75.5
Ch1m	1.92
Ch1w	-0.97
Ch1y	-12.02
Ch3m	6.14
Ch3y	-4.65
Ch5y	-15.89
Ch6m	-10.54
Change	-0.07%
Change From Open	0.35
Close	14.34
Days Gap	-0.42
Depreciation Amortization	14,022,473
Dollar Volume	5,003,047.2
Earnings Date	2026-10-26
EBIT	CNY 63.5M
EBITDA	CNY 77.5M
EPS	CNY 0.39
F Score	7
FCF	CNY 89.4M
FCF EV Yield	5.72x
FCF Per Share	CNY 0.56
Financing CF	-48,000,000
Fiscal Year End	December
Founded	1,998
Graham Number	6.89594
Graham Upside	-51.91
Income Tax	CNY 10.6M
Investing CF	-16,172,772
Is Primary Listing	1
Last Earnings Date	2025-10-24
Last Report Date	2026-06-30
Last Split Date	2017-07-04
Last Split Type	Forward
Lynch Fair Value	CNY 1.95
Lynch Upside	-86.41
Ma150	14.72
Ma150ch	-2.57%
Ma20	14.6
Ma20ch	-1.75%
Net CF	25,702,865
Next Earnings Date	2026-10-26
Open	14.28
P FCF Ratio	25.66
P OCF Ratio	25.53
Payment Date	2026-05-29
Position In Range	84.62
Ppne	86,364,670
Price Date	2026-09-08
Price EBITDA	CNY 29.6
Ptbv Ratio	2.79
Relative Volume	0.06x
Revenue	267,009,983x
Tax By Revenue	3.96x
Tax Rate	14.58%
Tr6m	-8.62%
Volume	349,131

SHE/300519 (SHE/300519)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300519

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300519 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/300519

Frequently asked questions